No Detail Found!

Is tranexamic acid really effective in the reducing the need for blood transfusion in patients undergoing total knee replacement?

Author(s)
Jamal Suleiman Alshawabkeh Department of Orthopedic Surgery, Jordanian Royal Medical Services,Amman,Jordan
Laith Khaled Al-tarawneh Department of Orthopedic Surgery, Jordanian Royal Medical Services,Amman,Jordan
Mahdi Saleh Jaradat Department of Orthopedic Surgery, Jordanian Royal Medical Services,Amman,Jordan
Mohammad Ali Alsukour Department of Orthopedic Surgery, Jordanian Royal Medical Services,Amman,Jordan
Belal Mofreh Altarawneh Department of Orthopedic Surgery, Jordanian Royal Medical Services,Amman,Jordan
Abstract
Objectives: To assess the efficacy of antifibrinolytic tranexamic acid (TXA) treatment in reducing preoperative and perioperative blood loss during total knee replacement (TKR). Methodology: We reviewed the records of 57 patients who had undergone unilateral TKR between February and April, 2016. Mean age of patients was 62.4 (48-81) years and mean BMI was 33.1±4.7. Exclusion criteria included patients with renal impairment defined as serum creatinine higher than 1.4, history of venous thromboembolism or known coagulopathy, revision cases and patients whom their anesthesia was converted to general anesthesia. Surgeries were performed by a team of 3 surgeons following the same protocol in blood loss management. Patients were divided in 2 groups; TXA group (group A), 30 patients received it intravenously in 2 doses perioperatively, one given before incision and other on closure before tourniquet release and a non tranexamic acid group (group B), 27 patients were followed without receiving TXA. A standard venous thromboembolism prophylaxis was given for all patients. The primary outcome was the amount perioperative blood loss and level of hemoglobin 2 days postoperatively and venous thromboembolism were secondary outcomes Results: Transfusion rate was zero in Group A wen compared to the control group where 4 (8%) patients required transfusion (P<0.05). Hemoglobin change from preoperative reading after 24 hour and 48 hour postoperatively was 1.5±0.5 in group A and 2.8±0.5 in group B (P<0.001).Conclusion: Preoperative and perioperative low doses of TXA were found to be safe, effective and easily accessible antifibrinolytic agent that significantly reduced blood loss and blood transfusion rate in patients undergoing TKR with no apparent increased risk of VTE. 
Publication Details
Page(s) 103-106
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 45, Issue: 1, Year: 2020

Request the full text from PASTIC

Keywords
Tranexamic acid, blood transfusion, total knee replacement
0

Citations

0

Downloads

51

Views